書誌事項
- タイトル別名
-
- The Effect of Oriental Medicine (Dai-Sai-Ko-Tou) with Probucol on Lipoprotein Metabolism in Non-Insulin Dependent Diabetics with Hypercholesterolemia
この論文をさがす
抄録
Probucol (P) is known to decrease plasma HDL-chol as well as the total cholesterol (TC) level. Dai-Sai-Ko-Tou (D), a traditional oriental medicine, which has been used to treat obesity, has recently been reported to raise plasma HDL-chol levels in animals. Our aim was to examine the effect of the administration of P together with D on lipoprotein metabolism. Twenty six Noninsulin diabetics with hypercholesterolemia were treated either with P only (Single-treated group: S group) or with P and D (Combined-treated group: C group) for 3 months. Both treatments decreased the TC, LDL-chol, Apo A-I and Apo B levels significantly. VLDL-chol (64±32→50±24mg/dl mean±S.D.) and Apo E (12±4→10±4) were also decreased significantly only in the C group. HDL-chol in the C group marginally increased, while that in the S group decreased. The ΔHDL-chol in each group (6±21 vs. -12±20) was significantly different. In the S group ΔHDL-chol was negatively correlated with ΔVLDL-chol (r=-0.86, p<0.001) or positively correlated with ΔApo E(r=0.61, p<0.05). But these findings were not found in the D group. The ΔApo A-I was diminished in the C group (-20±21 vs. -38±21, p<0.05). In conclusion, the addition of Dai-Sai-Ko-Tou to Probucol resulted in an increase in plasma HDL-chol, possibly through the suppression of the HDL-VLDL pathway, and decreased the degree of inhibition of HDL synthesis.
収録刊行物
-
- The Journal of Japan Atherosclerosis Society
-
The Journal of Japan Atherosclerosis Society 19 (9-10), 839-846, 1991
一般社団法人 日本動脈硬化学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679667557504
-
- NII論文ID
- 130006851632
- 80006189276
-
- ISSN
- 21858284
- 03862682
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可